FDA issued a Warning Letter to CP Pharmaceuticals on 11/16/2016 as a result of this inspection.
483 CP Pharmaceuticals Oct 2015
483 CP Pharmaceuticals Oct 2015Torrance Slayton FDA$119.00 - Available Now
FDA investigators audited the CP Pharmaceuticals - Wrexham, United Kingdom facility and issued 13 inspectional observations (via FDA 483) on 13 Oct 2015.
Add To Cart
- Category: Human Drugs
- Number of Observations: 13
- Inspection end: 13 Oct 2015
- Location: Wrexham, United Kingdom
- FEI: 3003369660